NYSE: GRDN

Guardian Pharmacy Services, Inc. (GRDN)

Guardian Pharmacy Services, Inc. is a public company that reports to the U.S. Securities and Exchange Commission and trades on NYSE under the ticker GRDN. Bright Analyst brings its financial statements, SEC filings, stock performance, news and peer comparisons together in one place, with AI analysis throughout.

Key facts

Ticker symbol
GRDN
Exchange
NYSE
SEC CIK
1802255
Official filings
SEC EDGAR

Research GRDN

  • Profile — Business description, headquarters, subsidiaries and corporate identifiers.
  • Financials — Income statement, balance sheet and cash flow from 10-K and 10-Q filings.
  • SEC Filings — Every 10-K, 10-Q and 8-K, readable inline with AI analysis.
  • Stock Analysis — Price chart, returns, technical indicators and related companies.
  • News — Latest headlines and press coverage.
  • Material Contracts — Material agreements filed as exhibits to SEC reports.
  • Benchmark — Stock performance against the S&P 500, Nasdaq-100 and Dow (through SPY, QQQ and DIA) and economic indicators.
  • Peer Comparison — Side-by-side financial ratios against industry peers.

Frequently asked questions

What is Guardian Pharmacy Services, Inc.'s stock ticker?

Guardian Pharmacy Services, Inc. trades under the ticker symbol GRDN on NYSE. Its SEC Central Index Key (CIK) is 1802255.

Where can I read Guardian Pharmacy Services, Inc.'s SEC filings?

The GRDN SEC Filings page lists the 10-K annual reports, 10-Q quarterly reports and 8-K current reports Guardian Pharmacy Services, Inc. has filed, with AI analysis. The original documents are also on SEC EDGAR.

How can I analyze GRDN's financial statements?

The GRDN Financials page shows Guardian Pharmacy Services, Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly, taken from its XBRL filings, with an AI analysis of each statement.

How does GRDN compare with its peers and the market?

The GRDN Peer Comparison page lines Guardian Pharmacy Services, Inc. up against industry peers on valuation, growth and profitability ratios, and the Benchmark page compares its stock with the S&P 500, the Nasdaq-100 and the Dow.

For information only — not investment advice.